MYCN Antikörper (AA 335-463)
Kurzübersicht für MYCN Antikörper (AA 335-463) (ABIN7874046)
Target
Alle MYCN Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Bindungsspezifität
- AA 335-463
-
Verwendungszweck
- MYCN Antibody / n-Myc
-
Aufreinigung
- Protein A/G affinity
-
Immunogen
- A recombinant human MYCN protein (within amino acids 335-463) was used as the immunogen for the MYCN antibody.
-
Isotyp
- IgG1
-
-
-
-
Applikationshinweise
- Optimal dilution of the MYCN antibody should be determined by the researcher.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 0.2 mg/mL
-
Buffer
- 0.2 mg/mL in 1X PBS with 0.1 mg/mL BSA (US sourced), 0.05 % sodium azide
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Aliquot the MYCN antibody and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles.
-
-
- MYCN (N-Myc Proto-Oncogene Protein (MYCN))
-
Andere Bezeichnung
- MYCN
-
Hintergrund
- The v-Myc oncogene, initially identified in the MC29 avian retrovirus, causes myelocytomas, carcinomas, sarcomas and lymphomas, and belongs to a family of oncogenes conserved throughout evolution. In humans, the family consists of five genes: c-Myc, N-Myc, R-Myc, L-Myc and B-Myc. Amplification of the N-Myc gene has been found in human neuroblastomas and cell lines. Its amplification correlates well with the stage of neuroblastoma disease. Immunological studies have shown that the human N-Myc gene encodes a nuclear phosphoprotein that exhibits relatively short (30 min) half life in vivo. The prototype member of the family, c-Myc p67, binds DNA in a sequence-specific manner subsequent to dimerization with a second basic region helix-loop-helix leucine zipper motif protein, designated Max.
-
UniProt
- P04198
Target
-